Trial 0S-10-3

A Randomized, Phase II Clinical Trial of a Controlled Diet Prior to Selected Chemotherapy Treatment in Breast and Prostate Cancer to Evaluate the Impact on Toxicity and Efficacy.

Type: Supportive Care
Phase: Phase II
Status: Open to Accrual
Treatments: Other
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  David Quinn, M.D.
Other Trial Staff:  Lusine Raddatz, D.M., Grace Facio, Coordinator, Lagrimas Ilagan, D.M., Margarita Carranza, D.M., Kristy Sartor Massopust, Coordinator, America Casillas-Lopez, D.M., Ileana Aldana, D.M., Bartolo Santos, R.N., Apoorva Vishwanath, D.M., Brigitte Torres, Coordinator, Kristy Watkins, R.N.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.